EUVIMEDEUVIMED entdecken
Crossref

Optimal Control of Directional False Discovery Rates in Large‐Scale Testing

Guozhu Tang, Yicheng Kang, Dongdong Xiang

Statistics in Medicine · 2025

DOI: 10.1002/sim.10329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Guozhu Tang und 2 weiteren Autor:innen. Beteiligte Einrichtung: KLATASDS-MOE, School of Statistics, East China Normal University, Shanghai, China. Hauptthemen laut MEDLINE: Gene Expression Profiling, Models, Statistical. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Shanghai Pilot Program for Basic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high‐throughput biomedical technology enables measurement of thousands of gene expression levels contemporaneously. A major task in analyzing these gene expression data is to identify both over‐expressed and under‐expressed genes. The popular two‐group models select the non‐null genes without further classifying them as overexpression or underexpression. Consequently, two‐group decision rules are unable to constrain the numbers of falsely discovered over‐expressed or under‐expressed genes respectively. We propose a general three‐group model that allows dependence between the test statistics and develop a decision rule that separately controls the two types of false discoveries. We show that the optimal decision rule in our three‐group model has a special monotonic structure. By making use of this monotonic structure, we can linearize the two‐directional false discovery rate constraints. We prove that our decision rule optimizes the expected number of true discoveries while controlling the proportions of falsely discovered over‐expressed and under‐expressed genes at desired levels simultaneously. The data‐driven versions of the proposed procedures are suggested, and their consistency is established. Comparisons with state‐of‐the‐art approaches and applications to genomic studies show that our procedures work well.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression ProfilingModels, StatisticalHumansFalse Positive ReactionsComputer SimulationData Interpretation, Statistical

Stichwörter der Autor:innen

monotone likelihood ratiomultiple testssignal classificationthree‐group models

Autor:innen und Institutionen

  • KLATASDS-MOE, School of Statistics, East China Normal University, Shanghai, China.
  • Department of Information Systems & Analytics, Miami University, Ohio, USA.

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Shanghai Pilot Program for Basic Research
  • Basic Research Project of Shanghai Science and Technology Commission
  • National Key Research and Development Program of China

Zitieren

APA

Tang, G., Kang, Y., & Xiang, D. (2025). Optimal Control of Directional False Discovery Rates in Large‐Scale Testing. Statistics in Medicine. https://doi.org/10.1002/sim.10329

Vancouver

Tang G, Kang Y, Xiang D. Optimal Control of Directional False Discovery Rates in Large‐Scale Testing. Statistics in Medicine. 2025. doi:10.1002/sim.10329

BibTeX
@article{Tang2025,
  author = {Tang, Guozhu and Kang, Yicheng and Xiang, Dongdong},
  title = {Optimal Control of Directional False Discovery Rates in Large‐Scale Testing},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.10329}
}
Kostenlos starten →